Ameritas Investment Partners, Inc. Clovis Oncology, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.63 - $2.96 $4,968 - $23,345	-7,887 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$5.02 - $7.05 $7,529 - $10,575	1,500 Added 23.49%	7,887 $46,000
Q2 2020 Aug 05, 2020	BUY	$5.69 - $9.69 $13,769 - $23,449	2,420 Added 61.0%	6,387 $43,000
Q2 2018 Aug 13, 2018	BUY	$42.06 - $62.4 $10,178 - $15,100	242 Added 6.5%	3,967 $180,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,725	3,725 $349,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.